NF2 and neoplasm: Consequently, in the absence of functional merlin in VS in patients with NF2-related SWN, these signaling pathways are activated and cause tumor growth.5 Therefore, agents targeting these classical oncogenic pathways or other more unknown pathways could potentially improve the treatment of these tumors.